Oxidation of Short and Medium Chain C2-C8 Fatty Acids in Sprague-Dawley Rat Colonocytes

Overview

Journal Gut

Specialty Gastroenterology

Date 1997 Mar 1

PMID 9135532

Citations 23

Authors

J R JORGENSEN

M R Clausen

P B Mortensen

Affiliations

Soon will be listed here.

Abstract

Background: The predominant colonic short chain fatty acids, acetate, propionate, and butyrate, are oxidised into CO2 in colonocytes from rat and humans in the preferred order of butyrate (C4) > propionate (C3) > acetate (C2)- hence butyrate is considered to be the principal oxidative substrate for colonocytes.

Aims: To compare colonocyte oxidation of valerate (C5), hexanoate (C6), and octanoate (C8) with that of butyrate.

Methods: Isolated rat colonocytes were incubated in the presence of a concentration range of 1-14C labelled C2-C8 fatty acids. Oxidation rates were obtained by quantifying the production of 14CO2, and Vmax (maximum velocity) and K(m) (Michaelis-Menten constant) were calculated by computer fitting of the data to a Michaelis-Menten plot.

Results: The K(m) value of acetate (0.56 (SEM 0.02) mmol/l) was about fourfold higher than the K(m) of butyrate (0.13 (0.01) mmol/l), whereas the K(m) values of valerate (0.19 (0.01) mmol/l), hexanoate (0.19 (0.01) mmol/l), and octanoate (0.16 (0.01) mmol/l) were of the same order of magnitude as the K(m) of butyrate. Acetate did not influence butyrate oxidation, whereas butyrate strongly inhibited the oxidation of acetate. By contrast, valerate, hexanoate, and octanoate inhibited colonocyte oxidation of butyrate equally or more than the reverse inhibitory effect of butyrate on valerate, hexanoate, and octanoate oxidation. The maximum rates of ATP production were in the order of valerate > octanoate = hexanoate > butyrate > acetate (28.47 (0.70), 21.78 (0.75), 21.33 (0.78), 16.12 (0.49), 9.09 (0.34) (mumol/min/g) respectively).

Conclusions: Valerate, hexanoate, and octanoate seem to be excellent substrates for colonocyte oxidation, similar to butyrate. These results may influence the choice of fatty acid composition in enemas used for treatment of patients in whom deficient colonocyte oxidation is suspected-for example, patients with ulcerative colitis and diversion colitis.

Citing Articles

The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease.

Hays K, Pfaffinger J, Ryznar R Gut Microbes. 2024; 16(1):2393270.

PMID: 39284033 PMC: 11407412. DOI: 10.1080/19490976.2024.2393270.

Effects of Nutritional Interventions on Athletic Performance.

Toon A, Bailey S, Roelands B Nutrients. 2023; 15(21).

PMID: 37960151 PMC: 10649019. DOI: 10.3390/nu15214498.

Gluconic acid improves performance of newly weaned piglets associated with alterations in gut microbiome and fermentation.

Michiels J, Truffin D, Majdeddin M, Van Poucke M, Van Liefferinge E, Van Noten N Porcine Health Manag. 2023; 9(1):10.

PMID: 37016456 PMC: 10074721. DOI: 10.1186/s40813-023-00305-1.

Sodium butyrate supresses malignant human mast cell proliferation, downregulates expression of KIT and promotes differentiation.

MacDonald C, Qian H, Pundir P, Kulka M Front Allergy. 2023; 4:1109717.

PMID: 36970068 PMC: 10036836. DOI: 10.3389/falgy.2023.1109717.

Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets.

Otte M, Tamang R, Papapanagiotou J, Ahmad R, Dhawan P, Singh A World J Gastroenterol. 2023; 29(7):1157-1172.

PMID: 36926666 PMC: 10011951. DOI: 10.3748/wjg.v29.i7.1157.

References

Harig J, SOERGEL K, Komorowski R, Wood C . Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989; 320(1):23-8. DOI: 10.1056/NEJM198901053200105. View

Whitehead R, Young G, Bhathal P . Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut. 1986; 27(12):1457-63. PMC: 1433981. DOI: 10.1136/gut.27.12.1457. View

Senagore A, Mackeigan J, SCHEIDER M, Ebrom J . Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum. 1992; 35(10):923-7. DOI: 10.1007/BF02253492. View

Finnie I, Taylor B, Rhodes J . Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut. 1993; 34(11):1552-8. PMC: 1374421. DOI: 10.1136/gut.34.11.1552. View

Clausen M, Mortensen P . Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology. 1994; 106(2):423-32. DOI: 10.1016/0016-5085(94)90601-7. View

Steinhart A, Brzezinski A, Baker J . Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol. 1994; 89(2):179-83. View

Chapman M, Grahn M, Boyle M, Hutton M, Rogers J, Williams N . Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut. 1994; 35(1):73-6. PMC: 1374636. DOI: 10.1136/gut.35.1.73. View

Hove H, Mortensen P . Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate. Dig Dis Sci. 1995; 40(6):1372-80. DOI: 10.1007/BF02065554. View

Bartram H, Scheppach W, Englert S, Dusel G, Richter A, Richter F . Effects of deoxycholic acid and butyrate on mucosal prostaglandin E2 release and cell proliferation in the human sigmoid colon. JPEN J Parenter Enteral Nutr. 1995; 19(3):182-6. DOI: 10.1177/0148607195019003182. View

10.

Clausen M, Mortensen P . Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut. 1995; 37(5):684-9. PMC: 1382875. DOI: 10.1136/gut.37.5.684. View

11.

Roediger W, TRUELOVE S . Method of preparing isolated colonic epithelial cells (colonocytes) for metabolic studies. Gut. 1979; 20(6):484-8. PMC: 1412458. DOI: 10.1136/gut.20.6.484. View

12.

McGarry J, Foster D . Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980; 49:395-420. DOI: 10.1146/annurev.bi.49.070180.002143. View

13.

Roediger W . The colonic epithelium in ulcerative colitis: an energy-deficiency disease?. Lancet. 1980; 2(8197):712-5. DOI: 10.1016/s0140-6736(80)91934-0. View

14.

Roediger W . Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980; 21(9):793-8. PMC: 1419533. DOI: 10.1136/gut.21.9.793. View

15.

KRUH J . Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem. 1982; 42(2):65-82. DOI: 10.1007/BF00222695. View

16.

Roediger W . Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology. 1982; 83(2):424-9. View

17.

Dexter D, Lev R, McKendall G, Mitchell P, Calabres P . Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells. Histochem J. 1984; 16(2):137-49. DOI: 10.1007/BF01003545. View

18.

Scheppach W, Sommer H, Kirchner T, Paganelli G, Bartram P, Christl S . Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992; 103(1):51-6. DOI: 10.1016/0016-5085(92)91094-k. View